New pill for tough blood cancers tested in early trial

NCT ID NCT06761586

Terminated Disease control Sponsor: Aurigene Discovery Technologies Limited Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study tested an oral drug called AUR104 in 9 adults with certain blood cancers (lymphomas and leukemia) that had come back or stopped responding to treatment. The main goal was to check the drug's safety and how the body processes it. The trial was terminated early, so its findings are limited.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AUR104 (oral drug)
What this could lead to: If successful, this could point toward a new treatment option for certain blood cancers that have stopped responding to standard therapy.
What could go wrong: This was a very early (Phase 1) and small (9 patients) trial that has already been terminated, so results may be limited or inconclusive. The drug may not prove safe or effective in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

B-cell chronic lymphocytic leukemia classic Hodgkin lymphoma Hodgkins lymphoma non-Hodgkin lymphoma Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SELECT RELAPSED/REFRACTORY LYMPHOID MALIGNANCIES

Contacts and locations

Show contact details

Locations

Adwaita Cancer Hospital & ICU

Surat, Gujarat, 395009, India
Kiran Multi Super Speciality Hospital and Research Centre

Surat, Gujarat, 395004, India
Kolhapur Cancer Centre Pvt. Ltd.

Kolhāpur, Maharashtra, 416234, India
MMFHA Joshi Hospital

Pune, Maharashtra, 411004, India
Sunshine Global Hospitals

Surat, Gujarat, 395007, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.